Evaluation of thyroid status of infants in intensive care settings: Recommended an extension of newborn screening

Journal of Pediatrics

Volumn 143, Issue 5, 2003, Pages 556-558

  Rapaport, Robert ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; IODINE; THYROTROPIN; THYROXINE;

CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DATA BASE; DIGEORGE SYNDROME; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; GENE CONTROL; GENE FUNCTION; GENETIC ANALYSIS; HEART DEVELOPMENT; HEX GENE; HUMAN; HYPOTHYROIDISM; INCIDENCE; INFANT; ITALY; NERVE CELL DIFFERENTIATION; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; PREMATURITY; PRIORITY JOURNAL; PUBLICATION; REGULATOR GENE; RISK FACTOR; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRISOMY 21; UNITED STATES; VERY LOW BIRTH WEIGHT;

EID: 0344874221     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00550-X     Document Type: Editorial

References (32)

1. Vidyasagar D. A global view of advancing neonatal health and survival. J Perinatol 2002;22:513-5.
2. Gressens P, Rogido M, Paindaveine B, Sola A. The impact of neonatal intensive care practices on the developing brain. J Pediatr 2002;140:646-53.
3. Perlman JM. Neurobehavioral deficits in premature graduates of intensive care-potential medical and neonatal environmental risk factors. Pediatrics 2001;108:1339-48.
4. Frank JE, Faix JE, Hermos RJ, Mulaney DM, Rojan DA, Mitchell ML, et al. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996;128:548-54.
5. Hunter MK, Mandel SH, Sesser DE, Miyahira RS, Rein L, Skeels MR, et al. Stimulating hormone-screening concentrations: results of the 20-year experience the Northwest Regional Newborn Screening Program. J Pediatr 1998;132:70-7.
6. Mandel SJ, Hermos RJ, Larson CA, Prigozhin AB, Rojas DA, Mitchell ML. Atypical hypothyroidism and the very low birth weight infant. Thyroid 2000;10:693-5.
7. Tylek-Lemaska D, Kumorowicz-Kopiec M, Dziatkowiak H, Rybakowa M, Suszniak A, Juroszek M, et al. TSH levels in newborns with low and very low birth vs rescreening for congenital hypothyroidism. Przegl Lek 2002;59(Suppl 1):114-6.
8. Rapaport R. Thyroid function in the very low birth weight newborn: rescreen or reevaluate? J Pediatr 2002;140:287-9.
9. Larson C, Hermos R, Delaney A, Haley D, Mitchell M. Risk factors associated with delayed TSH elevations in congenital hypothyroidism. J Pediatr 2003;143:587-91.
10. Weber G, Vigone MC, Rapa A, Bona G, Chiumello G, on behalf of the Italian Collaborative Study on Transient Hypothyroidism. Neonatal transient hypothyroid etiological study. Arch Dis Child Fetal Neonatal Ed 1998;79:F70-2.
11. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povideidone is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 1997;7:395-400.
12. Soukup T, Zacharova G, Smerdu V, Jirmanova I. Body, heart, thyroid gland, and skeletal muscle weight changes in rats with altered thyroid status. Physiol Res 2001;50:619-26.
13. Tuysuz B, Beker DB. Thyroid dysfunction in children with Down syndrome. Acta Paediatr 2001;90:1389-93.
14. Van Trotsenburg ASP, Vulsma T, Van Santen HM, Cheung W, De Vijlder JJM. Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 2003;88:1512-5.
15. Preece JM, Smith RA. Thyroid disease in children with 22q11.2 deletion syndrome [letter]. J Pediatr 2002;141:297.
16. Oliveri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, Spagnolo A, et al, The Study Group for Congenital Hypothyroidism. A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism, 1991-1998. J Clin Endocrinol Metab 2002;87:557-62.
17. Calaciura F, Miscio G, Coco A, Leonardi D, Cisternino D, Regalbuto C, et al. Genetics of specific phenotypes of congenital hypothyroidism: a population-based approach. Thyroid 2002;12:945-51.
18. Benson DW. The genetics of congenital heart disease: a point in the revolution. Cardiol Clin 2002;20:385-94.
19. Yatskievych TA, Pascoe S, Antin PB. Expression of the homeobox gene Hex during early stages of chick embryo development. Mech Dev 1999;80:107-9.
20. Puppin C, D'Elia AV, Pellizzari L, Russo D, Arturi F, Presta I, et al. Thyroid-specific transcription factors controls Hex promoter activity. Nucleic Acids Res 2003;31:1845-52.
21. Clark SJ, Deming DD, Emery JR, Adams LM, Carlton EI, Nelson JC. Reference ranges for thyroid function tests in premature infants beyond the first week of life. J Perinatol 2001;21:531-6.
22. Biswas S, Buffery J, Enoch H, Bland JM, Walters D, Markiewicz M. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-7.
23. Dembinski J, Arpe V, Kroll M, Bartmann P, Hieronimi G. Thyroid function in healthy and sick very low birth weight infants - thyrotropin and free thyroxine until the sixth week of age. Biol Neonate 2001;80:210-4.
24. Bartkowski R, Wojtalik M, Korman E, Sharma G, Henschke J, Mrowczyski W. Thyroid hormone levels in infants during and after cardiopulmonary bypass with ultrafiltration. Eur J Cardiothorac Surg 2002; 22:879-4.
25. Calaciura F, Motta RM, Miscio G, Fichera G, Leonardi D, Carta A, et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 2002;87:3209-14.
26. Moreno JC, Bikker H, Kemoers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95-102.
27. Vanbesien J, Casteels A, Bougatef A, DeCatte L, Foulon W, DeBock S, et al. Transient fetal hypothyroidism due to direct fetal administration of amiodarone for drug-resistant fetal tachycardia. Am J Perinatol 2001;18:113-5.
28. Golombek SG, LaGamma EF, Paneth N. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice. J Perinatol 2002;22:563-5.
29. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst 2001;Rev 4:CD001070.
30. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the pre-term infant: the benefits and risks of thyroxine treatment. J Pediatr 2001;139:182-8.
31. O'Shea TM, Goldstein DJ. Follow-up data. Their use in evidence-based decision-making. Clin Perinatol 2003;30:217-50.
32. Tyson JE, Stoll B. Evidence-based ethics and the care and outcome of extremely premature infants. Clin Perinatol 2003;30:363-87.